Vericel Corp

VCELNASDAQ · USD
40.02USD-0.01 (-0.03%)
699

Vericel Corp (VCEL) Option Chain

As of September 17, 2026, Vericel Corp is trading at $40.02, a -0.03% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 55.8%. IV Rank is 12%.

Read more

Tracking the VCEL option chain helps you see every strike and expiry on Vericel Corp in one view, so you can quickly identify the contracts that fit your thesis and your risk. Vericel Corp's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of VCEL options activity at a glance. Use our scanner to monitor the VCEL option chain in real time and filter for the VCEL options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For VCEL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the VCEL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where VCEL stock options are being actively traded and where they are not.

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns.

The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Vericel Corp's full chain across every expiry, highlights the most liquid strikes, and lets you screen VCEL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of VCEL stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile65.48% Neutral
  • Market cap (M$)2,050
  • 52 weeks high-18.84%
  • 52 weeks low38.27%
  • Analyst recommendationStrong Buy
    1.25
  • Target price$60.57
    51.35% above the current stock price
  • Dividend
  • Payout ratio0.00%
  • Earnings date2026-11-05
  • P/E86.61
  • Future P/E46.26
  • EPS (ttm)0.46
  • EPS growth next 5 years61.02%

As of September 17, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
3.69200.3310.028.0012.7030.00-25.063.900.003.900296.31
21.153200.585.023.208.0035.00-12.575.000.005.000178.85
52.131402.680.020.405.0040.00-0.070.155.000.002.580147.87
79.02702.530.000.055.0045.00+12.423.007.804.980.420020.98
93.08101.550.001.5550.00+24.917.9012.509.980.22006.92

As of September 17, 2026

Scan the full option chain in one place

Browse the full VCEL option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial